CEMI News and Press, Chembio Diagnostics Inc. From 10/23/20

HAUPPAUGE, N.Y., Oct. 23, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will release financial results for the third quarter 2020 after the close of trading on Thursday, ...

Chembio Diagnostics (CEMI) has submitted an application for Emergency Use Authorization ((EUA)) to the FDA for the DPP SARS-CoV-2 Antigen test system to detect COVID-19 antigens in only 20 minutes.The test system consists of a DPP SARS-CoV-2 Antigen test cartridge, a DPP Micro Reader optical ...

HAUPPAUGE, N.Y., Oct. 15, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced the submission of an application for Emergency Use Authorization (EUA) to the U.S. Food and Drug Admin...

Chembio Diagnostics suffered a significant setback in Q2 when the FDA revoked the emergency use authorization for its COVID-19 rapid-testing system. The company has submitted a new application with the FDA and expects and approval still this year allowing it to capture the high market...

3 Penny Stocks To Trade Or Fade Before The Opening Bell Penny stocks are high-risk/high-reward, that’s a given. But are you familiar with premarket trading? If you’re new to trading, you may not know what time the market opens. While most will start trading “...

The FDA has approved Chembio Diagnostics' (CEMI) Premarket Approval ((PMA)) application for the DPP HIV-Syphilis System including, a multiplex single-use test, and the DPP Micro Reader optical analyzer. It is being offered in the U.S. immediately. Under the PMA, the DPP HIV-Syphilis Syst...

HAUPPAUGE, N.Y., Oct. 02, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the Premarket Approval (PMA) application...

Penny Stocks To Watch This Week What’s one thing we can irrefutably confirm about penny stocks ? No matter how you slice it, you’re going to encounter a high-risk scenario compared to blue chip stocks . The lower price and higher volatility are just a few things to factor in. Y...

Chembio Diagnostics  (NASDAQ: CEMI )   +5.5% PM ,  initiated notification process and submission of an application for Emergency Use Authorization (EUA) to the U.S. FDA for its new rapid antibody test system, DPP SARS-CoV-2 IgM/IgG. More news on: Chembio Diagnostics, Inc., ...

Intra-Cellular Therapies (ITCI  +74%  on positive topline results from its Phase 3 clinical trial. More news on: Astrotech Corporation, Vaxart, Inc., Chembio Diagnostics, Inc., Stocks on the move, , Read more ...